174 related articles for article (PubMed ID: 3011677)
1. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families.
Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR
Infection; 1986; 14(2):60-3. PubMed ID: 3011677
[TBL] [Abstract][Full Text] [Related]
2. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
[No Abstract] [Full Text] [Related]
3. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
[TBL] [Abstract][Full Text] [Related]
5. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
6. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
7. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
[No Abstract] [Full Text] [Related]
8. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.
Greenberg AE; Schable CA; Sulzer AJ; Collins WE; Phuc Nguyen-Dinh
Lancet; 1986 Aug; 2(8501):247-9. PubMed ID: 2874279
[TBL] [Abstract][Full Text] [Related]
10. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins.
Lange JM; van den Berg H; Dooren LJ; Vossen JM; Kuis W; Goudsmit J
J Infect Dis; 1986 Jul; 154(1):171-4. PubMed ID: 3011923
[No Abstract] [Full Text] [Related]
11. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
[TBL] [Abstract][Full Text] [Related]
13. [Properties and transmission of the AIDS virus].
Laufs R
Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
[TBL] [Abstract][Full Text] [Related]
14. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
[TBL] [Abstract][Full Text] [Related]
15. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
Abb J
AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
[TBL] [Abstract][Full Text] [Related]
16. An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test.
Parry JV
J Med Virol; 1986 Aug; 19(4):387-97. PubMed ID: 3018141
[TBL] [Abstract][Full Text] [Related]
17. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.
Blumberg RS; Sandstrom EG; Paradis TJ; Neumeyer DN; Sarngadharan MG; Hartshorn KL; Byington RE; Hirsch MS; Schooley RT
J Clin Microbiol; 1986 Jun; 23(6):1072-7. PubMed ID: 2423552
[TBL] [Abstract][Full Text] [Related]
18. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
[TBL] [Abstract][Full Text] [Related]
19. HTLV-III/LAV infection in hemodialysis patients.
Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
